| 查看: 165 | 回复: 1 | |||||
谈判陶荣誉版主 (文坛精英)
如切如磋,如琢如磨
|
[求助]
微谱2
|
|
化合物2 18.0,25.8,27.6,37.3,61.3,75.1,78.5,111.2,122.4,136.0,146.6,173.0 CDCL3 |
» 猜你喜欢
酰胺脱乙酰基
已经有12人回复
售SCI一区文章,我:8 O5 51O 54,科目齐全
已经有3人回复
售SCI一区文章,我:8 O5 51O 54,科目齐全
已经有3人回复
同年申请2项不同项目,第1个项目里不写第2个项目的信息,可以吗
已经有4人回复
有时候真觉得大城市人没有县城人甚至个体户幸福
已经有10人回复
天津大学招2026.09的博士生,欢迎大家推荐交流(博导是本人)
已经有5人回复
有院领导为了换新车,用横向课题经费买了俩车
已经有5人回复
CSC & MSCA 博洛尼亚大学能源材料课题组博士/博士后招生|MSCA经费充足、排名优
已经有6人回复
面上项目申报
已经有3人回复
博士延得我,科研能力直往上蹿
已经有7人回复

wangkaibo123
荣誉版主 (职业作家)
kerry
-

专家经验: +726 - PhEPI: 3
- 应助: 1928 (讲师)
- 贵宾: 0.598
- 金币: 7869.1
- 散金: 10156
- 红花: 100
- 帖子: 3780
- 在线: 1007.1小时
- 虫号: 2088618
- 注册: 2012-10-26
- 性别: GG
- 专业: 抗肿瘤药物药理
- 管辖: 药学
【答案】应助回帖
★ ★ ★ ★ ★ ★ ★ ★
感谢参与,应助指数 +1
谈判陶: 金币+8, ★★★★★最佳答案, 谢谢,很及时 2013-12-11 12:52:50
感谢参与,应助指数 +1
谈判陶: 金币+8, ★★★★★最佳答案, 谢谢,很及时 2013-12-11 12:52:50
|
查询模式:模糊查询 碳谱数据输入: 按从小到大顺序输入,数字间用英文半角逗号(,)分隔例如: 21.4,30.4,37.4,73.2,73.7,125.6,126.6,139.6,140.2,168.2 溶剂选项: 匹配容差: (数字格式,可自行设定) 相似度: %(相似度>=50%) 查询结果:共查到89个化合物(查询结果仅供参考) 1 . vibralactone 相似度:91.6% Chemical & Pharmaceutical Bulletin 2008 56(9) 1286-1288 Derivatives of Vibralactone from Cultures of the Basidiomycete Boreostereum vibrans Meng-Yuan JIANG,Fei WANG,Xiao-Long YANG,Li-Zhen FANG,Ze-Jun DONG,Hua-Jie ZHU,and Ji-Kai LIU Structure 13C NMR 碳谱模拟图 2 . Vibralactone C12H16O3 相似度:91.6% Organic Letters 2006 8 5749-5752 Vibralactone: A Lipase Inhibitor with an Unusual Fused a-Lactone Produced by Cultures of the Basidiomycete Boreostereum vibrans Dong-Ze Liu, Fei Wang, Tou-Gen Liao,†Jian-Guo Tang,Wolfgang Steglich, Hua-Jie Zhu, and Ji-Kai Liu Structure 13C NMR 碳谱模拟图 3 . acetylated vibralactone C14H18O4 相似度:64.2% Chemical & Pharmaceutical Bulletin 2008 56(9) 1286-1288 Derivatives of Vibralactone from Cultures of the Basidiomycete Boreostereum vibrans Meng-Yuan JIANG,Fei WANG,Xiao-Long YANG,Li-Zhen FANG,Ze-Jun DONG,Hua-Jie ZHU,and Ji-Kai LIU Structure 13C NMR 碳谱模拟图 4 . compound 9 C12H18O4 相似度:58.3% Tetrahedron 2013 69 6512-6518 Unprecedented formation of a 14-membered dihydropyran macrocycle via sequential olefin cross metathesis-intramolecular hetero Diels–Alder reaction Kavirayani R. Prasad, S. Mothish Kumar Structure 13C NMR 碳谱模拟图 5 . 7,8 3,5-bis(3-methyl-2-butenyl)-4-methoxybenzoic acid 相似度:58.3% Planta Medica 2012 78 914-918 Dihydrochalcones and Benzoic Acid Derivatives from Piper dennisii Cabanillas, Billy Joel; Le Lamer, Anne-Cécile; Castillo, Denis; Arevalo, Jorge; Estevez, Yannick; Rojas, Rosario; Valadeau, Céline; Bourdy, Geneviève; Sauvain, Michel; Fabre, Nicolas: Structure 13C NMR 碳谱模拟图 6 . (±)-3-(2-hydroxy-3-methyl-3-butenyl)-4-methoxy-5-(3-methyl-2-butenyl)benzoic acid C18H24O4 相似度:56.2% Journal of Natural Products 2008 71(9) 1538-1543 Benzoic Acid Derivatives from Piper Species and Their Antiparasitic Activity Ninoska Flores, Ignacio A Jiménez, Alberto Giménez, Grace Ruiz, David Gutiérrez, Genevieve Bourdy, and Isabel L. Bazzocchi Structure 13C NMR 碳谱模拟图 7 . glionitrin A C13H11N3O5S2 相似度:53.8% Journal of Natural Products 2009 72 248-252 Glionitrin A, an Antibiotic-Antitumor Metabolite Derived from Competitive Interaction between Abandoned Mine Microbes Hyun Bong Park, Hak Cheol Kwon, Chang-Ho Lee, and Hyun Ok Yang Structure 13C NMR 碳谱模拟图 8 . compound 8 C13H22O2 相似度:53.8% Chemical & Pharmaceutical Bulletin 1996 44 41-47 Chemical Studies on Crude Drug Processing IX. On the Constituents of Rehmanniae Radix. 10). Absolute Stereostructures of Rehmaionosides A, B, and C, and Rehmapicroside, Biologically Active Ionone Glucosides and a Monoterpene Glucoside Isolated from Chines Masayuki YOSHIKAWA,Youichi FUKUDA,Toshio TANIYAMA and Isao KITAGAWA Structure 13C NMR 碳谱模拟图 9 . compound 9 C13H22O2 相似度:53.8% Chemical & Pharmaceutical Bulletin 1996 44 41-47 Chemical Studies on Crude Drug Processing IX. On the Constituents of Rehmanniae Radix. 11). Absolute Stereostructures of Rehmaionosides A, B, and C, and Rehmapicroside, Biologically Active Ionone Glucosides and a Monoterpene Glucoside Isolated from Chines Masayuki YOSHIKAWA,Youichi FUKUDA,Toshio TANIYAMA and Isao KITAGAWA Structure 13C NMR 碳谱模拟图 |

2楼2013-12-11 12:39:11













回复此楼